Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

C.S.E. Verbrugge, M.C.M. Al, Y.G. Assaraf, D. Niewerth, J. van Meerloo, J. Cloos, M.S. van der Veer, G.L. Scheffer, G.J. Peters, E.T. Chan, J.L. Anderl, C.J. Kirk, S. Zweegman, B.A.C. Dijkmans, W.F. Lems, R.J. Scheper, T.D. de Gruijl, G. Jansen

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)

Cite this